Biotech

All Articles

Basilea credit ratings $268M BARDA backing for antifungals, antibiotics

.Basilea Pharmaceutica's job creating brand new antifungals has received a significant increase from...

Capricor markets Europe legal rights to late-stage DMD treatment for $35M

.Having actually gathered up the U.S. liberties to Capricor Rehabs' late-stage Duchenne muscle dystr...

FDA fragments adcomm for Applied's rare health condition drug

.After dismissing the choice meeting for Applied Therapeutics' metabolic ailment medication govorest...

Novo inks $600M NanoVation bargain to study genetic drugs ex-liver

.Novo Nordisk is continuing its push into hereditary medicines, consenting to pay NanoVation Rehabs ...

Innovent web links cytokine to colon cancer reactions

.Innovent Biologics has actually produced the scenario that its own checkpoint inhibitor-cytokine co...

Merck, Daiichi ADC hits goal in stage 3 lung cancer study

.A stage 3 trial of Daiichi Sankyo and Merck &amp Co.'s HER3-directed antibody-drug conjugate (ADC) ...

Rakovina strengthens artificial intelligence focus along with collab to choose cancer cells targets

.5 months after Rakovina Rehabs rotated toward expert system, the cancer-focused biotech has signed ...

Ascendis' dwarfism medicine hits in phase 3, endangers BioMarin

.Ascendis Pharma has actually emerged as a potential hazard to BioMarin's Voxzogo, disclosing phase ...

Despite ph. 3 miss, Alkeus views path in advance for eye condition possession

.Though Alkeus Pharmaceuticals' dental eye condition resource fell short to dramatically reduce geog...

Kairos goes social along with $6M IPO to finance tests of cancer drug

.Along with a trio of biotechs attacking the Nasdaq on Friday, it was simple to miss a smaller-scale...